Debbie Payne-Turner Selected Research

Debbie Payne-Turner Research Topics

14	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 12/2010
8	Leukemia 01/2021 - 03/2013
5	Philadelphia Chromosome 09/2017 - 09/2014
3	Neoplasms (Cancer) 01/2017 - 12/2010
3	Residual Neoplasm 01/2017 - 04/2012
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 09/2017
1	Polycythemia (Erythrocytosis) 02/2016
1	Hypersensitivity (Allergy) 02/2016
1	Ewing Sarcoma (Sarcoma, Ewing) 12/2010

5	Phosphotransferases (Kinase)IBA 02/2017 - 08/2012
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 09/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2015
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2015
2	Protein Isoforms (Isoforms)IBA 09/2017 - 12/2016
2	Tyrosine Kinase InhibitorsIBA 02/2017 - 09/2014
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2017 - 08/2012
2	Tyrosine (L-Tyrosine)FDA Link 02/2016 - 01/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	talazoparibIBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	Decitabine FDA Link 01/2021
1	Erythropoietin FDA Link 02/2016
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 02/2016
1	RetinoidsIBA 09/2015
1	Ikaros Transcription FactorIBA 09/2015
1	Janus KinasesIBA 06/2015
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2013
1	Messenger RNA (mRNA)IBA 04/2012
1	NucleosidesIBA 12/2010
1	EWS-FLI fusion proteinIBA 12/2010
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2010

5	Therapeutics 01/2019 - 09/2014
2	Remission Induction 01/2017 - 09/2014
1	Immunotherapy 01/2020
1	Heterologous Transplantation (Xenotransplantation) 01/2020
1	Drug Therapy (Chemotherapy) 01/2017